Bromocriptine increased operant responding for high fat food but decreased chow intake in both obesity-prone and resistant rats

Behavioural Brain Research

Volumn 217, Issue 1, 2011, Pages 165-170

  Thanos, Panayotis K ^a,b,c   Cho, Jacob ^b   Kim, Ronald ^b,c   Michaelides, Michael ^b,c   Primeaux, Stefany ^d   Bray, George ^d   Wang, Gene Jack ^b   Volkow, Nora D ^a,b  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Addiction; D2; Diet; Dopamine; Hyperphagia

Indexed keywords

BROMOCRIPTINE; DOPAMINE; DOPAMINE 2 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEEDING BEHAVIOR; FOOD INTAKE; INSTRUMENTAL CONDITIONING; LIPID DIET; MALE; MOTIVATION; NONHUMAN; OBESITY; PALATABILITY; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REINFORCEMENT; REWARD; STRAIN DIFFERENCE; TASK PERFORMANCE;

ANIMALS; BROMOCRIPTINE; CONDITIONING, OPERANT; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; MALE; OBESITY; RATS; RATS, INBRED STRAINS; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; SPECIES SPECIFICITY;

EID: 78149328403     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.10.027     Document Type: Article

References (27)

1. Volkow N.D., Fowler J.S. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 2000, 10(3):318-325.
2. Volkow N.D., Fowler J.S., Wang G.-J., Swanson J.M., Telang F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol 2007, 64(11):1575-1579.
3. Wang G.J., Volkow N.D., Logan J., Pappas N.R., Wong C.T., Zhu W., et al. Brain dopamine and obesity. Lancet 2001, 357(9253):354-357.
4. Stice E., Spoor S., Bohon C., Small D.M. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 2008, 322(5900):449-452.
5. Thanos P.K., Michaelides M., Piyis Y.K., Wang G.-J., Volkow N.D. Food restriction markedly increases dopamine D2 receptor (D2R) in a rat model of obesity as assessed with in-vivo μPET Imaging ([11C] Raclopride) and in-vitro ([3H] Spiperone) autoradiography. Synapse 2008, 62:50-61.
6. Szczypka M.S., Rainey M.A., Kim D.S., Alaynick W.A., Marck B.T., Matsumoto A.M., et al. Feeding behavior in dopamine-deficient mice. Proc Natl Acad Sci USA 1999, 96(21):12138-12143.
7. Clifton P.G., Rusk I.N., Cooper S.J. Effects of dopamine D1 and dopamine D2 antagonists on the free feeding and drinking patterns of rats. Behav Neurosci 1991, 105(2):272-281.
8. Bina K.G., Cincotta A.H. Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice. Neuroendocrinology 2000, 71(1):68-78.
9. Doknic M., Pekic S., Zarkovic M., Medic-Stojanoska M., Dieguez C., Casanueva F., et al. Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. Eur J Endocrinol 2002, 147(1):77-84.
10. Scranton R.E., Gaziano J.M., Rutty D., Ezrokhi M., Cincotta A. A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either Cycloset or placebo. BMC Endocr Disord 2007, 7:3.
11. Schemmel R., Mickelsen O., Gill J.L. Dietary obesity in rats: body weight and body fat accretion in seven strains of rats. J Nutr 1970, 100(9):1041-1048.
12. Richardson N.R., Roberts D.C.S. Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 1996, 66:1-11.
13. Davis C. Psychobiological traits in the risk profile for overeating and weight gain. Int J Obes (Lond) 2009, 33(Suppl. 2):S49-53.
14. Rosval L., Steiger H., Bruce K., Israel M., Richardson J., Aubut M. Impulsivity in women with eating disorders: problem of response inhibition, planning, or attention?. Int J Eat Disord 2006, 39(7):590-593.
15. Guerrieri R., Nederkoorn C., Schrooten M., Martijn C., Jansen A. Inducing impulsivity leads high and low restrained eaters into overeating, whereas current dieters stick to their diet. Appetite 2009, 53(1):93-100.
16. Esposito-Smythers C., Spirito A., Rizzo C., McGeary J.E., Knopik V.S. Associations of the DRD2 TaqIA polymorphism with impulsivity and substance use: preliminary results from a clinical sample of adolescents. Pharmacol Biochem Behav 2009, 93(3):306-312.
17. Davis L.M., Michaelides M., Cheskin L.J., Moran T.H., Aja S., Watkins P.A., et al. Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity. Neuroendocrinology 2009, 89(2):152-162.
18. Clifton P.G., Rusk I.N., Cooper S.J. Stimulation and inhibition of food intake by the selective dopamine D2 agonist, N-0437: a meal pattern analysis. Pharmacol Biochem Behav 1989, 33(1):21-26.
19. Bellinger L., Lilley C., Langley-Evans S.C. Prenatal exposure to a maternal low-protein diet programmes a preference for high-fat foods in the young adult rat. Br J Nutr 2004, 92(3):513-520.
20. Soderpalm A.H., Hansen S. Alcohol alliesthesia: food restriction increases the palatability of alcohol through a corticosterone-dependent mechanism. Physiol Behav 1999, 67(3):409-415.
21. Evans D.W., Lewis M.D., Iobst E. The role of the orbitofrontal cortex in normally developing compulsive-like behaviors and obsessive-compulsive disorder. Brain Cogn 2004, 55(1):220-234.
22. Brown S.M., Manuck S.B., Flory J.D., Hariri A.R. Neural basis of individual differences in impulsivity: contributions of corticolimbic circuits for behavioral arousal and control. Emotion 2006, 6(2):239-245.
23. Berke J.D., Hyman S.E. Addiction, dopamine, and the molecular mechanisms of memory. Neuron 2000, 25(3):515-532.
24. Stuchlik A., Petrasek T., Vales K. Dopamine D2 receptors and alpha1-adrenoceptors synergistically modulate locomotion and behavior of rats in a place avoidance task. Behavi Brain Res 2008, 189(1):139-144.
25. Kelly M.A., Rubinstein M., Phillips T.J., Lessov C.N., Burkhart-Kasch S., Zhang G., et al. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci 1998, 18(9):3470-3479.
26. Schran H.F., Tse F.L., Bhuta S.I. Pharmacokinetics and pharmacodynamics of bromocriptine in the rat. Biopharm Drug Dispos 1985, 6(3):301-311.
27. 82Br] bromocriptine. J Pharmacol Exp Ther 1979, 221(1):31-35.